AYTU BIOPHARMA, INC Goodwill
AYTU BIOPHARMA, INC (AYTU) had Goodwill of $0 as of 2023-06-30, per its 10-K filed 2024-09-26.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2024-09-26
- 2023-06-30: Goodwill $0.00.
- 2022-06-30: Goodwill $0.00.
- 2022-03-31: Goodwill $8.64M.
- 2021-12-31: Goodwill $46.35M.
| Period end | Goodwill | Goodwill as first filed |
|---|---|---|
| 2023-06-30 | $0.00 10-K · filed 2024-09-26 | |
| 2022-06-30 | $0.00 10-K · filed 2023-10-12 | |
| 2022-03-31 | $8.64M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $46.35M 10-Q · filed 2022-05-16 | |
| 2021-09-30 | $46.35M 10-Q · filed 2022-05-16 | |
| 2021-06-30 | $65.80M 10-K · filed 2023-10-12 | |
| 2021-03-31 | $65.80M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $28.09M 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $28.09M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $28.09M 10-K · filed 2022-09-27 | $28.09M 10-K · filed 2020-10-06 |
| 2020-03-31 | $24.06M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $15.39M 10-Q · filed 2020-02-14 | |
| 2019-06-30 | $0.00 10-K · filed 2020-10-06 | |
| 2017-12-31 | $238.43K 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $238.43K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $238.43K 10-K · filed 2018-09-06 | |
| 2017-03-31 | $74.00K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $221.00K 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $221.00K 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $221.00K 10-K · filed 2017-08-31 | |
| 2016-03-31 | $221.00K 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $221.00K 10-Q · filed 2016-02-11 | |
| 2015-09-30 | $74.00K 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $74.00K 10-K · filed 2016-09-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |